UFP Industries Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw an 8% sales decline and lower profitability due to adverse weather, inflation, and macro headwinds. Strategic acquisitions and capacity expansions position the business for long-term growth, while cost controls and capital discipline remain priorities.
Fiscal Year 2025
-
Q4 2025 saw a 9% sales decline and pressured margins, but cost reductions and capacity expansions position the business for improved results in 2026. Deckorators is set for $100 million in incremental sales, and strong free cash flow supports ongoing M&A and shareholder returns.
-
Q3 2025 saw a 5% sales decline and 15% drop in adjusted EBITDA amid soft demand and pricing pressure, but structural improvements and cost actions support cautious optimism for 2026. Share repurchases, targeted M&A, and investments in automation and new products position the company for margin expansion and above-market growth.
-
Q2 2025 saw a 3.5% sales decline and 15% lower adjusted EBITDA amid soft demand and competitive pricing. Cost reduction, innovation, and targeted investments continue, with strong growth in Surestone decking and a robust balance sheet supporting dividends and buybacks.
-
Q1 2025 saw a 3% sales decline and 21% drop in adjusted EBITDA amid ongoing market headwinds, but sequential improvement and strong liquidity position the company for long-term growth. Retail is expected to rebound in the second half as new products and capacity come online.
Fiscal Year 2024
-
Q4 2024 saw declining sales and compressed margins due to weak demand and competitive pricing, but strong liquidity and cost actions position the company for growth. Segment results were mixed, with retail flat, packaging and construction down, and new product launches and M&A supporting future strategy.
-
Q3 2024 saw a 10% sales decline and 21% drop in adjusted EBITDA, with cost reduction initiatives underway and a strong balance sheet supporting long-term growth. Management expects continued demand softness into 2025 but remains optimistic due to new products and disciplined capital allocation.
-
Q2 sales fell 7% to $1.9B as pricing and demand softened, but EBITDA margin stayed strong at 10.7%. $1B in capital investments is planned over 24 months, with a focus on organic growth, cost control, and innovation. Market share gains and operational efficiencies are expected to offset near-term headwinds.